News & Updates

Show Multimedia Only
Young-onset diabetes programme provides DNA testing and precision preventive intervention to those at risk
Young-onset diabetes programme provides DNA testing and precision preventive intervention to those at risk
07 Nov 2025
Empagliflozin 25 mg confers greater kidney protection than SGLT2i 10 mg in T2D
Empagliflozin 25 mg confers greater kidney protection than SGLT2i 10 mg in T2D
03 Nov 2025 byChristina Lau

In patients with type 2 diabetes (T2D), empagliflozin 25 mg daily offers greater kidney protection than its 10 mg daily dose or dapagliflozin 10 mg daily, a retrospective cohort study in Hong Kong has shown.

Empagliflozin 25 mg confers greater kidney protection than SGLT2i 10 mg in T2D
03 Nov 2025